Contribute Try STAT+ Today

Google is again facing questions from regulators about its $2.1 billion bid for Fitbit. The biggest sticking point: How will the tech giant use Fitbit’s trove of health data?

Google is staring down the possibility of a sweeping antitrust investigation launched by regulators in the European Union, which would become the latest in a series of probes into the deal. But the tech giant could sidestep that investigation by making a binding pledge not to use Fitbit’s health data for advertising purposes, Reuters reported this week. The deadline for Google to make such a concession is July 13. The European Commission, which is overseeing the probe, is scheduled to make a decision by July 20.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.